Articles

Social enterprises: doing NHS business without the bureaucracy

20th October 2014

Social enterprises: doing NHS business without the bureaucracy Nisha Desai

Nisha Desai, head of medicines management at social enterprise company Provide, speaks to pharmaphorum about how such organisations are benefitting the NHS, prior to her appearance at a major London... Read more

Patients as partners in medicines development – the EUPATI project

17th October 2014

Patients as partners in medicines development – the EUPATI projectJan Geissler

As the head of EUPATI, a consortium of organisations working to put patients at the heart of drug R&D, Jan Geissler has seen first-hand how bringing patients and industry together... Read more

Pharma gets social: US FDA in Ebola social media crackdown

16th October 2014

Pharma gets social: US FDA in Ebola social media crackdownDaniel Ghinn

This month, Daniel Ghinn turns the spotlight on companies claiming to sell 'cures' for Ebola via social media channels and looks at how the US FDA is responding."This is to... Read more

Tunnah’s musings: When does pharma innovation really need to start?

15th October 2014

Tunnah’s musings: When does pharma innovation really need to start?Paul Tunnah

After chairing the first day of Pharma Engagement Live, Paul Tunnah muses on the changing commercial models within pharma and asks when innovation really needs to start in order to... Read more

News

Stem cell researchers closer to creating human organs

20th October 2014

Stem cell researchers closer to creating human organsStaff reporter

Researchers in the US have made functional intestinal tissue in the lab that could be used to test new drugs and - in time - even be transplanted into patients... Read more

Parkinson’s charity pushes industry collaboration

20th October 2014

Parkinson’s charity pushes industry collaboration Linda Banks

Parkinson's UK has appointed pharma industry expert Dr Arthur Roach as its research director to increase collaboration with industry.Dr Roach will lead Parkinson's UK's extensive £20 million research portfolio of... Read more

Regeneron's Eylea trumps rivals in NIH study

20th October 2014

Regeneron's Eylea trumps rivals in NIH studyAndrew McConaghie

Regeneron is claiming victory after a US-government sponsored trial has suggested its eye treatment Eylea is superior to its rivals in treating diabetic macular oedema.The US company has seized on... Read more

NICE swayed by long term Glivec data

17th October 2014

NICE swayed by long term Glivec dataAndrew McConaghie

NICE has reversed a long-standing block on using Glivec in GIST tumours, saying new evidence has persuaded it to change its mind.Final draft guidance published today proposes to recommend Novartis' Glivec... Read more

Audio & Video

Live debate Oct 29th - Managing diabetes…

AHdiabweb300x200c


Non-adherence to self-management regimens in diabetes is globally a widespread, costly and ultimately life threatening issue. 

Reasons for non-adherence are complex... View more

Live webinar: Is pharma brand marketing …

Kantar Health webinar


While pharma observers speculate on the death of outdated drug discovery and sales models, some critical wounds to... View more

View the conversation - Tweetchat: Manag…

Atlantis Healthcare diabetes Tweetchat


Working in partnership, Atlantis Healthcare and pharmaphorum conducted a Tweetchat focussed on the real world challenges patients face in managing... View more

Patient Opinion Leaders: Andrew Schorr

 

As a cancer survivor and passionate patient advocate, Andrew Schorr typifies the concept of a Patient Opinion Leader (POL). He is a contributor to the... View more

White Papers

Anchoring qualitative methodologies in b…

Anchoring qualitative methodologies in business intelligence using smartphone appsPaul Mannu

The use of smartphone apps in market research enables genuine 'in the moment' insight to help us really understand behaviour. Combining this with qualitative methods gives us a deeper insight into behaviours... View info

Opportunities and challenges around non-…

Opportunities and challenges around non-adherence and self‑management in diabetesDr Sinéad NíMhurchadha and Stephen Galt

Diabetes is a chronic condition, the prevalence of which has been escalating around the world for years. The significant consequences this has for healthcare budgets and patient wellbeing is well... View info

Diabetes in France

Diabetes in FranceJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Further News & Articles

White Paper: Pricing & Market Access Outlook 2014

Pricing and market access are key issues for the pharma industry as healthcare budgets continue to tighten and th... Read more

Articles

Getting the most out of technology for multichannel marketing

While every pharma company recognises the potential of multichannel marketing to optimize its engagement with prescr... Read more

Articles

FDA facing huge pressure as Ebola worsens

The Food and Drug Administration (FDA) told the US Congress yesterday it is working hard to clarify the framewor... Read more

News

EU funds innovative personalised brain cancer trials

Novel personalised brain cancer vaccines are entering phase I/II trials thanks to a €6 million grant from the EU... Read more

News

AbbVie withdraws Shire bid following US tax changes

AbbVie's board has recommended its stockholders vote against its proposed £31 billion buyout of Shire as a re... Read more

News

Roche tipped to lead Boehringer in IPF head-to-head

Patients in the US with serious lung disease idiopathic pulmonary fibrosis (IPF) have gone from no approved... Read more

News